European stocks closed broadly higher on Tuesday with investors largely making cautious moves, digesting mixed earnings updates and ...
European stocks closed weak on Friday with investors reacting to corporate earnings announcements, and assessing the Bank of England ...
Tobacco giant Philip Morris International (PMI) has doubled down on its move into the pharmaceutical sector, following up its recent acquisition of Fertin Pharma ... with Hikma, and other inhaled ...
Shares of Hikma Pharmaceuticals PLC HIK inched up 0.33% to £18.37 Monday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.65% to ...
Shares of Hikma Pharmaceuticals PLC HIK rallied 1.64% to £18.01 Thursday, on what proved to be an all-around poor trading ...
This page features the latest news about the Hikma Pharma ADR stock. U.K. stocks higher at close of trade; Investing.com United Kingdom 100 up 0.37% Investing.com – U.K. stocks were higher after ...
Hikma Pharmaceuticals Usa Inc was founded in 2011 and operates in Eatontown, United States. The company engages in the sector 'Pharmaceuticals, Medicinal Chemical & Botanical Products' (ISIC ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
General Anesthesia Drugs MarketThe global general anesthesia drugs market, valued at USD 4,978.1 million in 2023, is poised for steady growth, with projections indicating a compound annual growth rate ...
Australia's Sigma Healthcare's top shareholder HMC Capital has cut its stake in the company, days after the country's competition watchdog gave its nod to pharmacy chain Chemist Warehouse's backdoor ...
President and CEO of LSL Pharma. This press release may contain forward-looking statements as defined under applicable Canadian securities legislation. Forward-looking statements can generally be ...
Pioneers like Alnylam Pharmaceuticals have led the RNA interference field for years. Now, a crop of young biotechs is ...